Circulating tumor cells are detectable in the bloodstream of early-stage cancer patients.

I, H., P, K., D, B., S, A., A, A., I, H., M, M., & J, B. (2026). Beyond the Needle: Is Liquid Biopsy the Future of Veterinary Medicine?. doi.org. https://doi.org/10.3390/ijms27188183

X, L., J, Y., B, C., Z, Z., J, Z., M, Z., & Z, W. (2026). Clinical utility of circulating tumor-derived endothelial cells in lung cancer detection and prognosis prediction.. doi.org. https://doi.org/10.3892/ol.2026.15840

PS, P., D, B., C, M., S, C., A, G., & S, C. (2026). Liquid biopsy in breast cancer: current biomarker platforms and clinical applications.. doi.org. https://doi.org/10.37349/etat.2026.1002394

Y, Z., M, Z., Y, Z., J, B., Z, L., C, W., L, W., X, L., X, L., W, W., J, W., & L, M. (2026). Liquid biopsy: current applications and future directions.. doi.org. https://doi.org/10.1186/s43556-026-00533-1

A, K., CR, M., G, L., G, K., M, S., & A, A. (2026). Non-Invasive Diagnosis of Early Breast Cancer: Current and Emerging Liquid Biopsy Biomarkers.. doi.org. https://doi.org/10.3390/cancers18142344

E, O., V, M. S., C, C., H, O., JW, L., K, G., & V, A. (2026). Liquid biopsies for detection, characterization, and interception of therapy resistance in thoracic malignancies.. doi.org. https://doi.org/10.3389/fonc.2026.1806868

Κουλουρίδη, Α. (n.d.). Detection and comparison of Circulating Tumor Cells and circulating free DNA at patients with stage III colorectal cancer receiving three or six months of adjuvant chemotherapy. doi.org. https://doi.org/10.12681/eadd/58660